2,6-Dichlorobenzoic acid cesium salt | 142601-45-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2,6-Dichlorobenzoic acid cesium salt
• 英文别名: cesium;2,6-dichlorobenzoate
• CAS: 142601-45-4
• 化学式: C₇H₃Cl₂O₂*Cs
• 分子量: 322.911
• InChiKey: ZKKYHMYMJNGPAE-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  -1.64
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  40.1
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(溴甲基)丙烯酸甲酯 、 2,6-Dichlorobenzoic acid cesium salt 以 丙酮 为溶剂， 反应 4.0h， 以97%的产率得到2-(Methoxycarbonyl)Allyl 2,6-Dichlorobenzoate
  参考文献：
  名称：

  Studies toward Novel Peptidomimetic Inhibitors of Thioredoxin–Thioredoxin Reductase System

  摘要：

  Thioredoxins (Trx) are ubiquitous multifunctional low-molecular weight proteins that together with thioredoxin reductases (TrxR) participate in the maintenance of protein thiol homeostasis in NADPH-dependent reactions. An increasing number of data reveal that the Trx-TrxR system is an attractive target for anticancer therapies. In this work, we have elaborated a new and simple synthetic approach employing Ugi reaction to synthesize several new inhibitors of this system. The influence of various electrophilic fragments of this new class of compounds on the inhibition of the Trx-TrxR system was evaluated. As a result, a new compound 19a (SK053), which inhibits the activity of the Trx-TrxR system and exhibits antitumor activity, was obtained. Biologic analyses revealed that 19a inhibits induction of NF-kappa B and AP-1 and decreases H2O2 scavenging capacity in tumor cells. Altogether, we show that 19a is a novel potential antitumor peptidomimetic inhibitor that can be used as a starting compound for further optimization.

  DOI：

  10.1021/jm201359d

文献信息

• Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one
  申请人：Sanofi Winthrop Inc.

  公开号：US05556909A1

  公开（公告）日：1996-09-17

  Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives, pharmaceutical compositions containing them and methods for the treatment of degenerative diseases utilizing them.

  替代的2-芳基羰基氧甲基-1,2,5-噻二唑啉-3-酮1,1-二氧化物衍生物，含有它们的药物组合物以及利用它们治疗退行性疾病的方法。